SF Prep Notes

CCI approves Torrent Pharmaceuticals' acquisition of J.B. Chemicals with voluntary modifications

On 21 October 2025, the Competition Commission of India approved Torrent Pharmaceuticals' acquisition of J.B. Chemicals & Pharmaceuticals, subject to voluntary modifications offered by the parties.

Summary

On 21 October 2025, the Competition Commission of India (CCI) approved the proposed acquisition of J.B. Chemicals & Pharmaceuticals Limited by Torrent Pharmaceuticals Limited, subject to voluntary modifications offered by the parties. The deal covers Torrent's acquisition of shares in J.B. Chemicals followed by the amalgamation of J.B. Chemicals into Torrent. Torrent, the flagship company of the Torrent group, makes pharmaceutical formulations; J.B. Chemicals makes formulations and active pharmaceutical ingredients and provides contract development and manufacturing (CDMO) services.

Key facts

Regulator
Competition Commission of India
Acquirer
Torrent Pharmaceuticals Ltd
Target
J.B. Chemicals & Pharmaceuticals Ltd
Structure
Share acquisition, then amalgamation into Torrent
Condition
Voluntary modifications by parties

Practice MCQs 1 questions

Q1

In October 2025, the CCI approved the acquisition of J.B. Chemicals & Pharmaceuticals by which company, subject to voluntary modifications?

Show answer

Correct answer: C — Torrent Pharmaceuticals

PIB: the CCI approved the proposed acquisition of J.B. Chemicals & Pharmaceuticals Limited by Torrent Pharmaceuticals Limited with voluntary modifications.

← All current affairs